Find Clinical Trials
Safety and efficacy of S 38093 and donepezil, during 4 weeks, in patients with mild to moderate Alzheimer’s Disease. An international, multi-centre, randomised, double-blind, placebo controlled, phase II add-on study
Servier Protocol Code:
CL2-38093-009
Sponsor:
Institut de Recherches Internationales Servier (I.R.I.S)
EudraCT Number:
2009-012035-15
Find a recruiting site
Name:
Institut de Recherches Internationales Servier, Département des études cliniques
Phone number:
+33 1 55 72 60 00
Results
Interventions / Treatments
The treatment(s) given to the participants in the study.
- Alzheimer's disease
- S038093
Other study id numbers
Other identification numbers the study may be known by.
- CL2-38093-009